Liang Kong
Liang Kong
In the last 10 years, more and more clinical trials have come to China because of potential market/easy access of patient and cost-effectiveness, but if we look back, there had been minimum changes on the regulatory requirements, and there ...
Alessandro Gozzetti,Giulia Papini,Veronica Candi et al.
Alessandro Gozzetti et al.
The introduction of novel agents in multiple myeloma therapy has dramatically improved survival in latest years. Great progress has also been detected in particular poor clinical situation such as acute renal failure in which survival was d...
The Long Way to a Successful Medical Therapy of Heart Failure with Beta-blockers in Children with Heart Disease [0.03%]
通向儿童心脏病β受体阻滞剂成功治疗之路漫长
Reiner Buchhorn,Robert D Ross
Reiner Buchhorn
Heart failure remains the main cause of death in children with heart disease. In USA and Europe hospital mortality of children with heart failure is about 7% of children, nearly twice as high as in adults. In this review a group of authors ...
Beta-Blockers in Children with Congenital Heart Disease Before a Corrective Procedure [0.03%]
先天性心脏病患儿矫正手术前的β受体阻滞剂治疗
Reiner Buchhorn
Reiner Buchhorn
The prevalence of heart failure in patients with congenital heart disease, mainly due to large left to right shunts, is as high as 20%. Heart failure has a high impact on prognosis, growth and neurodevelopment. Prior to surgery or after pal...
Tsuyoshi Matsumura
Tsuyoshi Matsumura
Respiratory failure and heart failure are inevitable complications in Duchenne muscular dystrophy (DMD). Respiratory failure and heart failure undergo simultaneously and affect each other. After dissemination of mechanical ventilation, hear...
The Role of Beta-Blocker in Heart Failure in Adults with Congenital Heart Disease [0.03%]
成人先天性心脏病心力衰竭患者β受体阻滞剂的作用
Kambiz Norozi
Kambiz Norozi
Thanks to the enormous progress in the field of cardiac surgery and paediatric cardiology since the mid of 20th century, more and more children with congenital heart defects reach the adulthood. This on the other hand encounter physician an...
Ingegerd Östman-Smith
Ingegerd Östman-Smith
Congestive cardiac failure accounts for 36% of childhood deaths in hypertrophic cardiomyopathy, and in infants with heart failure symptoms before two years of age, the mortality is extremely high unless treatment with beta-receptor antagoni...
Sergej Prijic,Reiner Buchhorn
Sergej Prijic
Patients with chronic heart failure have prolonged sympathetic stimulation and subsequent worsening of the failing heart function. Beta-blockers (non-selective, cardio-selective, and non-selective with ancillary properties) counteract the e...
Beta-Blockers (Carvedilol) in Children with Systemic Ventricle Systolic Dysfunction - Systematic Review and Meta-Analysis [0.03%]
儿童全身性心室收缩功能障碍使用β阻滞剂（卡维地洛）的系统评价和meta分析
Sergej Prijic,Reiner Buchhorn,Jovan Kosutic et al.
Sergej Prijic et al.
Background: Numerous prospective randomized clinical trials demonstrated favorable effect of beta-blockers in adults with chronic heart failure. However, effectiveness of beta blockers in pediatric patients with systemic ...
Sivasubramanian Ramakrishnan
Sivasubramanian Ramakrishnan
The exact prevalence of heart failure among children of developing countries is not known, as the data is limited. The relative frequency of different causes of pediatric heart failure varies widely across different countries and even among...